Management issues in rheumatoid arthritis-associated interstitial lung disease.

Current Opinion in Rheumatology
Bryant R England, Daniel Hershberger

Abstract

Summarize recent evidence on the identification and management of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Clinical and subclinical interstitial lung disease (ILD) are frequent extra-articular manifestations of rheumatoid arthritis (RA). Better means of identifying and treating RA-ILD are needed to improve the prognosis, with a median survival of only 3-7 years after diagnosis. Several serum biomarkers are currently being evaluated for their ability to detect RA-ILD. Thorough evaluation and multidisciplinary discussion remains the gold standard for establishing the diagnosis of RA-ILD. Management is challenging with most RA disease-modifying antirheumatic drugs (DMARDs) linked to pneumonitis. Methotrexate is typically avoided in clinically significant ILD, although alternative therapies including leflunomide and biologic DMARDs also carry risks in RA-ILD. Antifibrotics appear to slow the progression of ILD, and a large phase II trial exclusively in RA-ILD is underway. In addition, smoking cessation, pulmonary rehabilitation, oxygen therapy, managing comorbidities, and lung transplantation evaluation are vital to improving patient outcomes in RA-ILD. With little high-quality evidence to guide the manag...Continue Reading

References

Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·E GabbayF R Lake
Apr 19, 2002·Journal of Korean Medical Science·Hyun Kyu ChangDae Sik Ryu
May 10, 2002·The European Respiratory Journal·S D ParryJ R Barton
Aug 19, 2003·Rheumatology·V Saravanan, C A Kelly
Apr 29, 2006·Arthritis and Rheumatism·Samy SuissaPierre Ernst
Jun 23, 2006·The New England Journal of Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Nov 6, 1948·British Medical Journal·P ELLMAN, R E BALL
Mar 27, 2009·Rheumatology·Batsi ChikuraJulie K Dawson
Mar 13, 2010·Rheumatology·Gouri KoduriUNKNOWN ERAS (Early Rheumatoid Arthritis Study)
Feb 1, 2011·Seminars in Arthritis and Rheumatism·Roberto Perez-AlvarezManuel Ramos-Casals
Apr 17, 2012·Respiratory Medicine·Aryeh FischerJeffrey J Swigris
Mar 19, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Arash YazdaniShikha Mittoo
Aug 26, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Lisa HarlowDana P Ascherman
Oct 11, 2014·Arthritis & Rheumatology·Juan ChenDana P Ascherman
Mar 31, 2015·American Journal of Respiratory and Critical Care Medicine·Tracy J DoyleIvan O Rosas
May 29, 2015·Arthritis & Rheumatology·Anne-Marie QuirkePatrick J Venables
Jul 16, 2015·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN Latin American Thoracic Association
Nov 8, 2015·Arthritis & Rheumatology·Jasvinder A SinghTimothy McAlindon
Nov 21, 2015·The European Respiratory Journal·Joshua J SolomonJeffrey J Swigris
Nov 28, 2015·Rheumatic Diseases Clinics of North America·Jameel YoussefKevin L Winthrop
Nov 28, 2015·Rheumatic Diseases Clinics of North America·Xena Whittier, Kenneth G Saag
Oct 28, 2016·Arthritis & Rheumatology·Jorge A Zamora-LegoffEric L Matteson
Jan 31, 2017·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Andrew M CourtwrightHilary J Goldberg
Feb 23, 2017·European Respiratory Review : an Official Journal of the European Respiratory Society·Emily C BellAnne E Holland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.